TRANSCEND · Transcending limitations of translational research on Multiple Sclerosis and Autism Spectrum Disorder - Spectral, brain-related disorder, patient outcomes, cognition, effect, symptoms
„Хоризонт Европа“ — Действия „Мария Склодовска-Кюри“
- Период
- 2025-09-01 → 2029-08-31
- Финансиране от ЕС
- 4 023 427 €
- Участници
- 22
- Схема
- HORIZON-TMA-MSCA-DN
Линиите свързват координатора с партньорите.
Накратко на български
Сложността на разстройствата от аутистичния спектър и рассеяната склероза се анализира чрез обединяване на биологични, клинични и социални данни. Интегративният подход помага да се разберат реалните симптоми и нуждите на пациентите, вместо да се разглеждат само отделни причини за заболяванията.
Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.
Цел на проекта
TRANSCEND brings together expertise in biomedical, computational, behavioural, clinical, epidemiological and philosophicalresearch to advance translational research in medicine. TRANSCEND aims to add to the chronological and epistemic order of research from bench to bedside to practice with a more networked-based understanding of translation. This is particularly important in translational research on complex and chronic neurological conditions where the few low-hanging fruits of reductionist approaches seem to have been picked. TRANSCEND involves nine interlinked laboratories from clinical, biomedical, metamethodological, and philosophical sub-projects, which focus on autism spectrum disorder and multiple sclerosis. These conditions are characterised by an interconnected set of physical, cognitive and psychological symptoms, and unknown underlying disease mechanisms. While healthcare has been moving away from a purely single-cause view of medicine towards interconnected concepts of positive health, such a more complicated and nuanced notion of health and dis/ability is unintegrated within biomedical research. Most research designs are not well-suited to consider patient-relevant outcomes, the biological and social complexity of these conditions, and their implications in real-world healthcare settings, because their epistemology is oriented towards purification and reduction concerning research questions, disease models, and experiments.TRANSCEND proposes an integrative approach to translational research that embraces instead of reduces the complexity and diversity of the biological, clinical and social manifestations of the diagnoses. It will provide an innovative, interdisciplinary training along four research objectives to overcome key limitations of translational research on complex, chronic conditions: (1) making animal models more translational; (2) focusing on patient outcomes and scoping “disease” categories; (3) rethinking theragnostic strategies.
Оригинален текст от CORDIS (на английски).
Участници
- AARHUS UNIVERSITET · Aarhus CКоординаторДания
- BUNDESMINISTERIUM FUER GESUNDHEIT · BonnГермания
- EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH · ZuerichШвейцария
- European Animal Research Association · Bruxelles / BrusselБелгия
- INK BV · AmsterdamНидерландия
- Idorsia Pharmaceuticals Ltd · AllschwilШвейцария
- KATHOLIEKE UNIVERSITEIT LEUVEN · LeuvenБелгия
- KOBENHAVNS UNIVERSITET · KOBENHAVNДания
- OSPEDALE SAN RAFFAELE SRL · MilanoИталия
- Orikami B.V. · NijmegenНидерландия
- SABER BIO · ParisФранция
- STICHTING AMSTERDAM UMC · AmsterdamНидерландия
- STICHTING RADBOUD UNIVERSITEIT · NijmegenНидерландия
- Stichting MS Research · VoorschotenНидерландия
- UNIVERSIDADE DO PORTO · PortoПортугалия
- UNIVERSITA VITA-SALUTE SAN RAFFAELE · MilanoИталия
- UNIVERSITAET BIELEFELD · BielefeldГермания
- UNIVERSITAIR MEDISCH CENTRUM UTRECHT · UtrechtНидерландия
- UNIVERSITE BORDEAUX MONTAIGNE · PESSAC CEDEXФранция
- UNIVERSITEIT UTRECHT · UtrechtНидерландия
- UNIVERSITETET I OSLO · OsloНорвегия
- VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG · AmsterdamНидерландия
Връзки
Данни: CORDIS, © Европейски съюз
